Movatterモバイル変換


[0]ホーム

URL:


JPS60173457A - Biosensor - Google Patents

Biosensor

Info

Publication number
JPS60173457A
JPS60173457AJP59030542AJP3054284AJPS60173457AJP S60173457 AJPS60173457 AJP S60173457AJP 59030542 AJP59030542 AJP 59030542AJP 3054284 AJP3054284 AJP 3054284AJP S60173457 AJPS60173457 AJP S60173457A
Authority
JP
Japan
Prior art keywords
electrode
blood
layer
fabric
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59030542A
Other languages
Japanese (ja)
Other versions
JPH0430543B2 (en
Inventor
Mariko Kawaguri
真理子 河栗
Shiro Nankai
史朗 南海
Takashi Iijima
孝志 飯島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panasonic Holdings Corp
Original Assignee
Matsushita Electric Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matsushita Electric Industrial Co LtdfiledCriticalMatsushita Electric Industrial Co Ltd
Priority to JP59030542ApriorityCriticalpatent/JPS60173457A/en
Publication of JPS60173457ApublicationCriticalpatent/JPS60173457A/en
Publication of JPH0430543B2publicationCriticalpatent/JPH0430543B2/ja
Grantedlegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

PURPOSE:To obtain a biosensor which can measure easily and quickly the specific component in a blood with high accuracy by providing a measuring electrode and counter electrode on an insulating substrate, coating the substrate with a prescribed reactive layer and porous filter layer and depositing an anticoagulant on one of the coating layers. CONSTITUTION:Platinum is embedded to an insulating (PVC) substrate 10 to provide a measuring electrode 11 and a counter electrode 12. A nonwoven nylon fabric 13 is installed to cover the electrode system. The fabric 13 carries glucose oxidase 14 as oxidation reduction enzyme and potassium ferricyanide 15 as an oxidation type dye to be conjugated to the oxidation reduction enzyme in a dry state after said fabric is impregnated into the soln. thereof. A filter layer 16 consisting of porous polycarbonate is installed onto the fabric 13. An anticoagulant (NaCl) is deposited on the layer 16. A blood is dropped to such sensor and the potential of the measuring electrode 11 is swept (0-0.5V) on the basis of the electrode 12, then the oxidation current is measured, by which the concn. of the glucose in the blood is detected. The specific component in the blood is thus easily and quickly measured with good accuracy.

Description

Translated fromJapanese

【発明の詳細な説明】産業上の利用分野本発明は、血液中の特定成分を迅速、かつ容易に定量す
ることのできるバイオセンサに関するものである。
DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to a biosensor that can quickly and easily quantify specific components in blood.

従来例の構成とその問題点近年、酵素の有する特異的触媒作用を利用した種々のバ
イオセンサが開発され、特に臨床検査分野への応用が試
みられている。検査項目及び検体数が増加している現在
、迅速に精度よく測定できるバイオセンサが望まれてい
る。
Structures of Conventional Examples and Their Problems In recent years, various biosensors that utilize the specific catalytic action of enzymes have been developed, and attempts have been made to apply them particularly to the field of clinical testing. Currently, as the number of test items and specimens increases, a biosensor that can perform measurements quickly and accurately is desired.

グルコースセンサに例をとると、糖尿病の増加が激しい
今日、血液中の血糖値を測定し管理するには、以前のよ
うに血液を遠心分離し血漿にして測定するのでは非常に
時間がかかるため、全面で測定できるセンサが要求され
ている。簡易型としては、尿検査の時に使用されている
検査紙と同様に、スティック状の支持体に糖(グルコー
ス)にのみ反)ムする酵素および酵素反応時又は酵素反
応の生成物により変化する色素を含有する相体を設置し
7/コものがある0、この担体に血液を添加し、一定時
間後の色素の変化を目又は光により測定する方式である
が、血液中の色素による妨害が大きく精度は低い。
Taking glucose sensors as an example, in today's world where diabetes is rapidly increasing, measuring and managing blood glucose levels requires a lot of time to centrifuge blood and convert it into plasma, as was done in the past. , a sensor that can measure the entire surface is required. A simple type, similar to the test strips used in urine tests, is a stick-shaped support containing an enzyme that reacts only with sugar (glucose) and a dye that changes during the enzyme reaction or by the products of the enzyme reaction. In this method, blood is added to this carrier and the change in pigment is measured by eye or light after a certain period of time, but there is interference from the pigment in the blood. It is large and the accuracy is low.

そこで、第1図のような多層式の分析担体が開発さね、
ている。透明な支持体1の上に試薬層2、展開層3、防
水層4、顔過層6が順に積層した構造となっている。血
液ザンプルを上部から滴下すると、捷ずρ渦層5により
血液中の赤血球、血小板などの固形成分が除去され、防
水層4にある小孔4aから展開層3へ均一に浸透し、試
薬層2において反応が進行する。反応終了後、透明な支
持体1を通して矢印の方向から光をあて、分光分析によ
り基質濃度を測定する方式である。従来の簡易なスティ
ック状の担体にくらべ、複雑な構造であるが、血球除去
などにより精度は向上した。しかし、血液の浸透および
反応に時間がかがるため、ザンブルの乾燥を防ぐ防水層
4が必要とな−たり、反応を速めるだめに高温でインキ
ュベートスル必要があり、装置および担体が複雑化する
という問題かある。
Therefore, a multilayer analytical carrier as shown in Figure 1 was developed.
ing. It has a structure in which a reagent layer 2, a spreading layer 3, a waterproof layer 4, and a face layer 6 are laminated in this order on a transparent support 1. When a blood sample is dropped from the top, solid components such as red blood cells and platelets in the blood are removed by the ρ vortex layer 5 without being strained, and the blood sample permeates uniformly into the spreading layer 3 through the small holes 4a in the waterproof layer 4, and the reagent layer 2 The reaction proceeds at . After the reaction is completed, light is irradiated through the transparent support 1 in the direction of the arrow, and the substrate concentration is measured by spectroscopic analysis. Although it has a more complex structure than the conventional simple stick-shaped carrier, it has improved accuracy due to blood cell removal. However, since it takes time for blood to permeate and react, a waterproof layer 4 is required to prevent the sample from drying out, and in order to speed up the reaction, it is necessary to incubate at a high temperature, which complicates the equipment and carrier. There is a problem.

最近、酵素反応と電極反応を結びっけて基質濃度を測定
するバイオセンサが開発されている。グルコースセンサ
に例をとると、第2図のように、グルコースオキシダー
ゼ固定化電極6を容器7に入わ7、緩衝液8で満たし、
スターテ9で撹拌している中に試料液を添加する。グル
コースオキシダーゼ固定化電極6には定電圧か印加され
ており、試料中のグルコースと反応して生成した過酸化
水素を検知して電流が流れグルコース濃度が測定できる
。この方式を用いバーば、血液中の色素なとに妨害され
ず迅速に測定できる。しかし、撹拌装置か不可欠なため
アワが発生したり、液の乱れが精度に影響するという問
題かあった。又希釈しているため、緩衝液の量や試料の
添加量に精度が要求され操作が複雑化する不都合があっ
た。
Recently, biosensors have been developed that measure substrate concentration by combining enzyme reactions and electrode reactions. Taking a glucose sensor as an example, as shown in FIG. 2, a glucose oxidase immobilized electrode 6 is placed in a container 7 and filled with a buffer solution 8.
Add the sample solution while stirring with Starter 9. A constant voltage is applied to the glucose oxidase immobilized electrode 6, and hydrogen peroxide produced by reaction with glucose in the sample is detected, and a current flows to measure the glucose concentration. Using this method, measurements can be made quickly without being interfered with by pigments in the blood. However, since a stirring device was required, there were problems such as bubbles occurring and turbulence of the liquid affecting accuracy. Furthermore, since the method is diluted, precision is required in the amount of buffer solution and the amount of sample added, making the operation complicated.

発明の目的本発明は、上記の問題点を克服し、血液中の特定成分を
簡易に、迅速かつ精度よく測定できるバイオセンサを1
号ることを目的とする。
Purpose of the Invention The present invention overcomes the above problems and provides a biosensor that can easily, quickly, and accurately measure specific components in blood.
The purpose is to issue a message.

発明の構成本発明のバイオセンサは、絶縁性の基板上に少なくとも
測定極と対極からなる電極系を有し、前記電極系を少な
くとも酸化還元酵素および酸化還とする。
Structure of the Invention The biosensor of the present invention has an electrode system consisting of at least a measurement electrode and a counter electrode on an insulating substrate, and the electrode system includes at least a redox enzyme and a redox enzyme.

本発明ノバイオセンサを用いることに」=す、血液中の
特定成分の測定を簡易に、精度よく測定することかでき
る、実施例の説明本発明のバイオセンサの1つとして、グルコースセンサ
を例に説明する。第3図にグルコースセンサの一実施例
の模式図を示す。塩化ビニル樹脂からなる絶縁性の基板
10に白金を埋め込み、測定極11と対極12とする。
By using the biosensor of the present invention, specific components in blood can be easily and accurately measured.Description of Examples As one of the biosensors of the present invention, a glucose sensor is used as an example. Explain. FIG. 3 shows a schematic diagram of an embodiment of a glucose sensor. Platinum is embedded in an insulating substrate 10 made of vinyl chloride resin to form a measurement electrode 11 and a counter electrode 12.

前記電極系を覆うように、ナイロン不織布13を設置す
る。このナイロン不織布13は、酸化還元酵素としてグ
ルコースオキシダーゼ14と酸化還元酵素と共役する酸
化型色素としてフェリシアン化カリウム15を、溶解含
浸後乾燥状態で担持している。このナイロン不織布13
の上部に、多孔性(孔径1μm)のポリカーボネートか
らなるp渦層16を設置する。
A nylon nonwoven fabric 13 is placed so as to cover the electrode system. This nylon nonwoven fabric 13 supports glucose oxidase 14 as an oxidoreductase and potassium ferricyanide 15 as an oxidized pigment conjugated with the oxidoreductase in a dry state after being dissolved and impregnated. This nylon nonwoven fabric 13
A p-vortex layer 16 made of porous (pore diameter 1 μm) polycarbonate is installed on top of the p-vortex layer 16 .

このセンサに血液を滴下して含浸させると、沖過層によ
り赤血球などの大きな分子が沖過され、ナイロン不織布
13からなる反応層において血液中のグルコースがグル
コースオキシダーゼ14により酸化される際、フェリシ
アン化カリウム15か共役して還元されフェリシアン化
カリウムが生成する。このフェリシアン化カリウムを、
対極12を基準に測定極11の電位をoVから+0.5
V寸でo、1V 7秒の速度で掃引することにより酸化
する。この時間られる酸化電流は、フェリシアン化カリ
ウムの濃度に比例し、フェロシアン化カリウムは基質濃
度に比例して生成するため、酸化電流を測定することに
より基質であるグルコースの濃度が検知できる。得られ
た電流値は、グルコースの標準液で測定したところ、8
00mg/d71Iまでグルコースの濃度とよい直線性
を示した。酵素と酸化型色素からなる反応層および濾過
層は、測定毎に交換しだが、標準液および血液のサンプ
ル両方において再現性は良好であった。又、血液の添加
量を20μβ〜140μlまで変化させだが、酸化型色
素及び酵素量が充分々だめ、添加量に関係なく一定の値
を示した。
When this sensor is dripped with blood and impregnated, large molecules such as red blood cells are filtered out by the overlayer, and when glucose in the blood is oxidized by glucose oxidase 14 in the reaction layer made of nylon nonwoven fabric 13, potassium ferricyanide 15 is conjugated and reduced to produce potassium ferricyanide. This potassium ferricyanide,
The potential of the measurement electrode 11 is +0.5 from oV with respect to the counter electrode 12.
Oxidize by sweeping at a speed of 1 V and 7 seconds with V dimension. This time-consuming oxidation current is proportional to the concentration of potassium ferricyanide, and since potassium ferrocyanide is produced in proportion to the substrate concentration, the concentration of the substrate glucose can be detected by measuring the oxidation current. The obtained current value was measured with a glucose standard solution and was 8.
It showed good linearity with the glucose concentration up to 00 mg/d71I. Although the reaction layer and filtration layer consisting of enzyme and oxidized dye were replaced after each measurement, reproducibility was good for both standard solutions and blood samples. Furthermore, although the amount of blood added was varied from 20 μ.beta. to 140 μl, the amounts of oxidized pigment and enzyme were sufficiently reduced and remained constant regardless of the amount added.

濾過層16として、ポリカーボネートの多孔体を用いる
ことにより、血液中の血球や粘性の物質があらかじめ濾
過でき、電極の汚れを少なくすることができた。濾過層
が々いと、長期間使用しているうちに電極上に血球が付
着し、得られる電流値が低下するだめ、電極をアルコー
ルで洗浄する必要があったが、濾過層により電極を水洗
だけで応答が再現性よく保持できるようになった。又、
ポリカーボネートの多孔体を界面活性剤で処理すること
により親水性をもだせることができる。界面活性剤とし
て例えばポリエチレングリコールアルキルフェニルエー
テル(商品名ニトリトンx)の1%溶液中に浸漬後乾燥
して使用すると、血液の濾過かすみやかになり、再現性
がさらに向上した。
By using a polycarbonate porous body as the filtration layer 16, blood cells and viscous substances in the blood could be filtered out in advance, and staining of the electrodes could be reduced. If the filtration layer is too thick, blood cells will adhere to the electrode after long-term use, reducing the current value obtained, so it was necessary to wash the electrode with alcohol, but with the filtration layer, it is now possible to simply wash the electrode with water. The response can now be maintained with good reproducibility. or,
Hydrophilicity can be imparted to a porous polycarbonate body by treating it with a surfactant. When used as a surfactant, for example, by immersing it in a 1% solution of polyethylene glycol alkyl phenyl ether (trade name Nitriton

さらに、濾過層に抗凝血剤であるフッ化ナトリウム溶液
を含浸後乾燥して担持させたところ、血液がわずか10
秒で濾過できだ。血液は粘性が高いだめ濾過に時間がか
かりすぎると凝血が始まり濾過層を通過できなくなると
いう問題があった。
Furthermore, when the filtration layer was impregnated with a sodium fluoride solution, which is an anticoagulant, and then dried to support it, only 10
It can be filtered in seconds. Since blood is highly viscous, there is a problem that if it takes too long to filter, blood will start to coagulate and will not be able to pass through the filter layer.

抗凝血剤を用いることにより濾過かすみやかになり、常
に安定に測定でき、測定の迅速化にも大きな効果があっ
た。
The use of an anticoagulant made the filtration hazy, allowing stable measurements at all times, and had a significant effect on speeding up measurements.

測定極および対極に白金を用いて2電極系で測定する場
合は、対極の面積を測定極のよりより十分大きくした方
か、対極の分極が少なくなり、良好な応答が得られる。
When measuring with a two-electrode system using platinum for the measurement electrode and the counter electrode, a good response can be obtained by making the area of the counter electrode sufficiently larger than that of the measurement electrode, or the polarization of the counter electrode will be reduced.

又、対極を銀塩化銀にすると、電位は安定する。Furthermore, when silver chloride is used as the counter electrode, the potential becomes stable.

第4図のように、塩化ビニル樹脂からなる基板1oに白
金を埋め込み、測定極11.対極12、および参照極1
7からなる3電極で電極系を構成した。参照極を用いだ
3電極とすることにより、2電極に比較して、応答再現
性が向上した。また、上記に述べた様に対極面積を大き
くする必要もなくなり小型化できた。又、白金を基板上
にスノくツタ法や蒸着法により白金層を形成して電極系
とすることも可能である。
As shown in FIG. 4, platinum is embedded in a substrate 1o made of vinyl chloride resin, and measurement electrodes 11. Counter electrode 12, and reference electrode 1
The electrode system was composed of three electrodes consisting of 7. By using three reference electrodes, response reproducibility was improved compared to two electrodes. Furthermore, as mentioned above, there is no need to increase the area of the counter electrode, and the size can be reduced. Further, it is also possible to form an electrode system by forming a platinum layer on a substrate by a snow vine method or a vapor deposition method.

酸化型色素及び酵素よりなる反応層は、試料液をすみや
かに吸収し酵素反応をおこなわせることかできるように
、親水性の多孔体膜であることが望ましい。たとえば、
ろ紙やパルプの不織布、セラミックやカラスの多孔体な
どを用いると、試料液が均一にすばやく浸透し再現性も
良好であった。
The reaction layer consisting of the oxidized dye and the enzyme is preferably a hydrophilic porous membrane so that the sample liquid can be quickly absorbed and the enzyme reaction can be carried out. for example,
When filter paper, pulp nonwoven fabric, ceramic or glass porous materials were used, the sample liquid penetrated uniformly and quickly, and the reproducibility was also good.

さらに、ナイロン不織布において、前記の界面活性剤で
処理したものは、処理しなかったものより試料液の浸透
がすみやかであり、測定の迅速化に効果かあった。
Furthermore, in the nylon nonwoven fabrics treated with the above-mentioned surfactant, the sample solution permeated more quickly than in the untreated fabrics, which was effective in speeding up the measurement.

酵素と酸化型色素を細かく粉砕混合後、加圧した成形体
を反応層とすると、血液の液体成分によりすみやかに溶
は均一に混合するため、反応の迅速化に大きく貢献した
。!、た、酸化型色素と酵素を加圧成形する際、結着剤
として、8102 などを少量混合すると、成形体の強
度か増すので取り扱いが簡易となる。結着剤としては、
酵素反応及び電極反応に無関係で親水性のものが適して
いる。
By using a molded product made by finely pulverizing and mixing enzymes and oxidized pigments and pressurizing them as the reaction layer, the liquid components of blood quickly and uniformly mixed the solution, which greatly contributed to speeding up the reaction. ! Additionally, when press molding the oxidized dye and enzyme, mixing a small amount of 8102 or the like as a binder increases the strength of the molded product, making it easier to handle. As a binder,
Hydrophilic materials that are unrelated to enzyme reactions and electrode reactions are suitable.

酸化型色素および酵素は、なるべく血液の液体成分に速
く溶ける状態におくことが望捷しい。そこで、酸化型色
素の溶液をナイロン不織布に含浸後、熱風乾燥すると、
真空乾燥したものより非常に細かい結晶となり、液体に
とけやすくな−だ。
It is desirable that the oxidized pigment and enzyme be in a state where they dissolve as quickly as possible in the liquid components of blood. Therefore, by impregnating a nylon nonwoven fabric with a solution of oxidized dye and drying it with hot air,
The crystals are much finer than those dried in vacuum, and they dissolve more easily in liquids.

又、酸化型色素の溶液を浸漬したナイロン不織布を、エ
タノールのような水に対する溶解度の大きい有機溶媒中
に浸漬後真空乾燥すると、さらに細かい結晶を担持する
ことができた。酵素は熱などに弱いため、含浸後真空乾
燥を行なった。
Furthermore, when a nylon nonwoven fabric soaked in a solution of an oxidized dye was immersed in an organic solvent with high solubility in water, such as ethanol, and then vacuum-dried, even finer crystals could be supported. Since enzymes are sensitive to heat, vacuum drying was performed after impregnation.

そこで、第6図の構成からなるセンサを試みだ。Therefore, we tried a sensor with the configuration shown in Figure 6.

電極系は第4図と同様で、その土にポリカーボネート多
孔体膜からなる濾過層16、次にグルコースオキシダー
ゼ14を担持したナイロン不織布18、その上部にフェ
リンアン化カリウム15を含浸後江タノールに浸漬し乾
燥して担持したナイロン不織布19を設置する。なお−
ポリカーボネート多孔体膜およびナイロン不織布は、あ
らかじめ前記の界面活性剤で処理し、抗凝血剤であるフ
ッ化ナトリウノ、を含浸後乾燥して相持した。
The electrode system was the same as that shown in Fig. 4, and the soil was impregnated with a filtration layer 16 made of a porous polycarbonate membrane, then a nylon nonwoven fabric 18 carrying glucose oxidase 14, and potassium ferrinanide 15 on top of the nylon nonwoven fabric 18, which was then immersed in ethanol. A dried and supported nylon nonwoven fabric 19 is installed. Note-
The polycarbonate porous membrane and the nylon nonwoven fabric were treated in advance with the above-mentioned surfactant, impregnated with sodium fluoride, which is an anticoagulant, and then dried and bonded together.

このセンサに血液を添加すると、抗凝血剤により凝血す
ることなく、すみやかにナイロン不織布の層に浸透し、
フェリシアン化カリウム15とグルコースオキシダーゼ
14が溶解して反応が進みながら、血液の液体成分のみ
1濾過層16を通過し電極系に至る。フェリシアン化カ
リウムを細かい結晶状態で411持しであるので、すみ
やかに溶解し酵素と共役して反応でき、反応時間か約1
分間以内と短縮できた。濾過層は、第5図のように電極
上においても1反応層の上部においてもよい。又、色素
担持層19と酵素担持層18ではさんでもよい。液の浸
透は、濾過層が反応層の下に設置した時が一番早く反応
時間が短かかった。
When blood is added to this sensor, it quickly penetrates the nylon nonwoven layer without clotting due to the anticoagulant.
While potassium ferricyanide 15 and glucose oxidase 14 are dissolved and the reaction progresses, only the liquid component of the blood passes through one filtration layer 16 and reaches the electrode system. Potassium ferricyanide is in a fine crystalline state and has a 411 concentration, so it can be dissolved quickly and conjugated with enzymes for reaction, and the reaction time is about 1.
I was able to shorten it to less than a minute. The filtration layer may be placed on the electrode or on top of one reaction layer as shown in FIG. Alternatively, it may be sandwiched between the dye-supporting layer 19 and the enzyme-supporting layer 18. The liquid permeation was fastest and the reaction time was shortest when the filtration layer was placed below the reaction layer.

しかし、反応層の上部K濾過層を設置すると、先に血液
中の固体成分が濾過できるので、反応層において血球な
どによる妨害がないため、スムーズに反応が進むという
利点があり、高精度であった。
However, if a K filtration layer is installed above the reaction layer, the solid components in the blood can be filtered out first, so there is no interference from blood cells in the reaction layer, and the reaction proceeds smoothly, resulting in high precision. Ta.

濾過層としては、不織布、化学繊維1紙(濾紙)カラス
の多孔体なとか考えられる。血球をfi過するだめには
孔径が2〜3μm以下であることが必要である。血球l
濾過か可能な均一な孔径のメンブランフィルタ−やカラ
スの多孔体が適している。
Possible filter layers include non-woven fabric, chemical fiber paper (filter paper), and glass porous materials. In order to pass through blood cells, the pore size must be 2 to 3 μm or less. blood cells l
Membrane filters or glass porous bodies with uniform pore diameters that allow filtration are suitable.

色素としては、上記に用いだフェリシアン化カリウムか
安定に反応するので適しているが、P −ベンゾキノン
を使えば、反応速度が早いので高速化に適している。又
、2.6−/クロロフェノールIイントフユノール、メ
チレンブルー、フェナ/ンメトザルフェ−1・、β−ナ
フトキ/ン4−スルホン酸カリウムなとも使用できる。
Potassium ferricyanide used above is suitable as the dye because it reacts stably, but P-benzoquinone is suitable for increasing the reaction rate because it has a fast reaction rate. In addition, 2,6-/chlorophenol I intofunol, methylene blue, phenanemethosulfe-1, β-naphthoquinone 4-potassium sulfonate can also be used.

抗凝血剤としてd、フッ化すトリウムが安定で取扱いも
簡易なため適しているか、ヘパリンやクエン酸ナトリウ
ム、エチレン/アミン四酢酸も血液濾過を迅速におこな
わせるのに有用であった。
As an anticoagulant, thorium fluoride is suitable because it is stable and easy to handle, and heparin, sodium citrate, and ethylene/aminetetraacetic acid are also useful for rapidly performing blood filtration.

なお、上記実施例におけるセンサはグルコース、f、<
 限う−r−アルコールセンザやコレステロールセンサ
など、酸化童元酵素の開力する系に用いることができる
。又、酵素は固定化した状態で担持することにより長期
保存においても安定に活性を維持することができる。
Note that the sensor in the above embodiment has glucose, f, <
It can be used in systems that activate oxidized enzymes, such as r-alcohol sensors and cholesterol sensors. Furthermore, by supporting the enzyme in an immobilized state, the activity can be stably maintained even during long-term storage.

発明の効果本発明のセンサによれは、直接血液を含浸させて微量の
特定成分を簡易に、しかも迅速に精度よく測定すること
ができる。また、1濾過層により、電極を長期間安定に
保持できる。さらに、抗凝血剤を担持することにより、
血液を凝血させることなくすみやかに濾過させ、反応時
間を短縮することができる。
ADVANTAGEOUS EFFECTS OF THE INVENTION The sensor of the present invention allows direct impregnation with blood to easily, quickly, and accurately measure minute amounts of specific components. Furthermore, the single filtration layer allows the electrode to be stably maintained for a long period of time. Furthermore, by carrying an anticoagulant,
Blood can be quickly filtered without clotting, and reaction time can be shortened.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図及び第2図は従来のグルコースセンサの構成を示
す図、第3図、第4図及び第5図は本発明の実施例であ
るグルコースセンサの模式図である。10 ・基板、11・・・・・・測定極、12・・・対
極、13・ ・・多孔体(反応層)、14 ・・・・酵
素、15・・・・・・色素、16・・・・・・濾過層、
17・・・・・参照極。
1 and 2 are diagrams showing the configuration of a conventional glucose sensor, and FIGS. 3, 4, and 5 are schematic diagrams of a glucose sensor that is an embodiment of the present invention. 10...Substrate, 11...Measurement electrode, 12...Counter electrode, 13...Porous body (reaction layer), 14...Enzyme, 15...Dye, 16... ...filtration layer,
17...Reference pole.

Claims (1)

Translated fromJapanese
【特許請求の範囲】(1)絶縁性の基板上に、少なくとも測定極と対極から
なる電極系を設け、この電極系を酸化還元酵素および酸
化還元酵素と共役する酸化型色−を含有する反応層およ
び多孔性の濾過層で被覆するとともに、前記反応層およ
び濾過層の少なくとも一方に抗血凝固剤を担持させたバ
イオセンサ。(2)測定極が白金である特許請求の範囲第1項記載の
バイオセンサ。(3)対極か白金又は銀塩化銀である特許請求の範囲第
1項記載のバイオセンサ。(4)反応層および濾過層が親水性を有する多孔体膜で
ある特許請求の範囲第1項記載のバイオセンサ。を乾燥状態で保持されている特許請求の範囲第4項記載の
バイオセンサ。(6)電極系が測定極、対極及び参照極の3電極で構成
され、いずれの電極も白金である特許請求の範囲第1項
記載のバイオセンサ。
[Claims] (1) An electrode system consisting of at least a measurement electrode and a counter electrode is provided on an insulating substrate, and this electrode system is used for a reaction containing an oxidized color conjugated with an oxidoreductase and an oxidation reductase. A biosensor that is coated with a porous filtration layer and a porous filtration layer, and an anticoagulant is supported on at least one of the reaction layer and the filtration layer. (2) The biosensor according to claim 1, wherein the measurement electrode is made of platinum. (3) The biosensor according to claim 1, wherein the counter electrode is platinum or silver-silver chloride. (4) The biosensor according to claim 1, wherein the reaction layer and the filtration layer are porous membranes having hydrophilic properties. 5. The biosensor according to claim 4, wherein the biosensor is kept in a dry state. (6) The biosensor according to claim 1, wherein the electrode system is composed of three electrodes: a measurement electrode, a counter electrode, and a reference electrode, all of which are made of platinum.
JP59030542A1984-02-201984-02-20BiosensorGrantedJPS60173457A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
JP59030542AJPS60173457A (en)1984-02-201984-02-20Biosensor

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
JP59030542AJPS60173457A (en)1984-02-201984-02-20Biosensor

Publications (2)

Publication NumberPublication Date
JPS60173457Atrue JPS60173457A (en)1985-09-06
JPH0430543B2 JPH0430543B2 (en)1992-05-22

Family

ID=12306678

Family Applications (1)

Application NumberTitlePriority DateFiling Date
JP59030542AGrantedJPS60173457A (en)1984-02-201984-02-20Biosensor

Country Status (1)

CountryLink
JP (1)JPS60173457A (en)

Cited By (29)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5288636A (en)*1989-12-151994-02-22Boehringer Mannheim CorporationEnzyme electrode system
US5508171A (en)*1989-12-151996-04-16Boehringer Mannheim CorporationAssay method with enzyme electrode system
WO1998020332A1 (en)*1996-11-071998-05-14Sensalyse Holdings LimitedBiosensor incorporating a surfactant
USRE36268E (en)*1988-03-151999-08-17Boehringer Mannheim CorporationMethod and apparatus for amperometric diagnostic analysis
US5997817A (en)*1997-12-051999-12-07Roche Diagnostics CorporationElectrochemical biosensor test strip
JP2002506209A (en)*1998-03-042002-02-26セラセンス、インク. Electrochemical analyte sensor
EP2324767A1 (en)*1998-03-042011-05-25Abbott Diabetes Care Inc.Process for producing an electrochemical biosensor
US9042953B2 (en)1998-04-302015-05-26Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9039975B2 (en)2006-03-312015-05-26Abbott Diabetes Care Inc.Analyte monitoring devices and methods therefor
US9066697B2 (en)1998-04-302015-06-30Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9066695B2 (en)1998-04-302015-06-30Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9078607B2 (en)2005-11-012015-07-14Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9610034B2 (en)2001-01-022017-04-04Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9662057B2 (en)2000-06-272017-05-30Abbott Diabetes Care Inc.Integrated sample acquisition and analyte measurement method
US9669162B2 (en)2005-11-042017-06-06Abbott Diabetes Care Inc.Method and system for providing basal profile modification in analyte monitoring and management systems
US9668684B2 (en)2009-02-262017-06-06Abbott Diabetes Care Inc.Self-powered analyte sensor
US9743863B2 (en)2006-03-312017-08-29Abbott Diabetes Care Inc.Method and system for powering an electronic device
US9801545B2 (en)2007-03-012017-10-31Abbott Diabetes Care Inc.Method and apparatus for providing rolling data in communication systems
US9891185B2 (en)1998-10-082018-02-13Abbott Diabetes Care Inc.Small volume in vitro analyte sensor
US9962091B2 (en)2002-12-312018-05-08Abbott Diabetes Care Inc.Continuous glucose monitoring system and methods of use
US9980670B2 (en)2002-11-052018-05-29Abbott Diabetes Care Inc.Sensor inserter assembly
US10039881B2 (en)2002-12-312018-08-07Abbott Diabetes Care Inc.Method and system for providing data communication in continuous glucose monitoring and management system
US10201301B2 (en)2005-11-012019-02-12Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US10478108B2 (en)1998-04-302019-11-19Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
USD902408S1 (en)2003-11-052020-11-17Abbott Diabetes Care Inc.Analyte sensor control unit
US11045147B2 (en)2009-08-312021-06-29Abbott Diabetes Care Inc.Analyte signal processing device and methods
US12239463B2 (en)2020-08-312025-03-04Abbott Diabetes Care Inc.Systems, devices, and methods for analyte sensor insertion
US12268496B2 (en)2017-01-232025-04-08Abbott Diabetes Care Inc.Systems, devices and methods for analyte sensor insertion
US12274548B2 (en)2006-10-232025-04-15Abbott Diabetes Care Inc.Sensor insertion devices and methods of use

Cited By (54)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
USRE36268E (en)*1988-03-151999-08-17Boehringer Mannheim CorporationMethod and apparatus for amperometric diagnostic analysis
US5508171A (en)*1989-12-151996-04-16Boehringer Mannheim CorporationAssay method with enzyme electrode system
US5288636A (en)*1989-12-151994-02-22Boehringer Mannheim CorporationEnzyme electrode system
AU720663B2 (en)*1996-11-072000-06-08Sensalyse Holdings LimitedBiosensor incorporating a surfactant
WO1998020332A1 (en)*1996-11-071998-05-14Sensalyse Holdings LimitedBiosensor incorporating a surfactant
USRE43815E1 (en)1997-12-052012-11-20Roche Diagnostics Operations, Inc.Electrochemical biosensor test strip
USRE42953E1 (en)1997-12-052011-11-22Roche Diagnostics Operations, Inc.Electrochemical biosensor test strip
USRE41309E1 (en)1997-12-052010-05-04Roche Diagnostics Operations, Inc.Electrochemical biosensor test strip
US5997817A (en)*1997-12-051999-12-07Roche Diagnostics CorporationElectrochemical biosensor test strip
USRE42560E1 (en)1997-12-052011-07-19Roche Diagnostics Operations, Inc.Electrochemical biosensor test strip
USRE42924E1 (en)1997-12-052011-11-15Roche Diagnostics Operations, Inc.Electrochemical biosensor test strip
JP2012011208A (en)*1998-03-042012-01-19Abbott Diabetes Care IncElectrochemical analyte sensor
JP5021115B2 (en)*1998-03-042012-09-05アボット ダイアベティス ケア インコーポレイテッド Electrochemical analyte sensor
JP2002506209A (en)*1998-03-042002-02-26セラセンス、インク. Electrochemical analyte sensor
EP2324767A1 (en)*1998-03-042011-05-25Abbott Diabetes Care Inc.Process for producing an electrochemical biosensor
US9042953B2 (en)1998-04-302015-05-26Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9066697B2 (en)1998-04-302015-06-30Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9066694B2 (en)1998-04-302015-06-30Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9066695B2 (en)1998-04-302015-06-30Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US10478108B2 (en)1998-04-302019-11-19Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9891185B2 (en)1998-10-082018-02-13Abbott Diabetes Care Inc.Small volume in vitro analyte sensor
US9662057B2 (en)2000-06-272017-05-30Abbott Diabetes Care Inc.Integrated sample acquisition and analyte measurement method
US9610034B2 (en)2001-01-022017-04-04Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US11141084B2 (en)2002-11-052021-10-12Abbott Diabetes Care Inc.Sensor inserter assembly
US10973443B2 (en)2002-11-052021-04-13Abbott Diabetes Care Inc.Sensor inserter assembly
US11116430B2 (en)2002-11-052021-09-14Abbott Diabetes Care Inc.Sensor inserter assembly
US9980670B2 (en)2002-11-052018-05-29Abbott Diabetes Care Inc.Sensor inserter assembly
US10750952B2 (en)2002-12-312020-08-25Abbott Diabetes Care Inc.Continuous glucose monitoring system and methods of use
US10039881B2 (en)2002-12-312018-08-07Abbott Diabetes Care Inc.Method and system for providing data communication in continuous glucose monitoring and management system
US9962091B2 (en)2002-12-312018-05-08Abbott Diabetes Care Inc.Continuous glucose monitoring system and methods of use
USD914881S1 (en)2003-11-052021-03-30Abbott Diabetes Care Inc.Analyte sensor electronic mount
USD902408S1 (en)2003-11-052020-11-17Abbott Diabetes Care Inc.Analyte sensor control unit
US11911151B1 (en)2005-11-012024-02-27Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US10201301B2 (en)2005-11-012019-02-12Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US10231654B2 (en)2005-11-012019-03-19Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US11399748B2 (en)2005-11-012022-08-02Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US11363975B2 (en)2005-11-012022-06-21Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US11272867B2 (en)2005-11-012022-03-15Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US10952652B2 (en)2005-11-012021-03-23Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9078607B2 (en)2005-11-012015-07-14Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US11103165B2 (en)2005-11-012021-08-31Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9669162B2 (en)2005-11-042017-06-06Abbott Diabetes Care Inc.Method and system for providing basal profile modification in analyte monitoring and management systems
US11538580B2 (en)2005-11-042022-12-27Abbott Diabetes Care Inc.Method and system for providing basal profile modification in analyte monitoring and management systems
US9625413B2 (en)2006-03-312017-04-18Abbott Diabetes Care Inc.Analyte monitoring devices and methods therefor
US9039975B2 (en)2006-03-312015-05-26Abbott Diabetes Care Inc.Analyte monitoring devices and methods therefor
US9743863B2 (en)2006-03-312017-08-29Abbott Diabetes Care Inc.Method and system for powering an electronic device
US12274548B2 (en)2006-10-232025-04-15Abbott Diabetes Care Inc.Sensor insertion devices and methods of use
US9801545B2 (en)2007-03-012017-10-31Abbott Diabetes Care Inc.Method and apparatus for providing rolling data in communication systems
US9668684B2 (en)2009-02-262017-06-06Abbott Diabetes Care Inc.Self-powered analyte sensor
US10631768B2 (en)2009-02-262020-04-28Abbott Diabetes Inc.Self-powered analyte sensor
US11045147B2 (en)2009-08-312021-06-29Abbott Diabetes Care Inc.Analyte signal processing device and methods
US12279894B2 (en)2009-08-312025-04-22Abbott Diabetes Care Inc.Analyte signal processing device and methods
US12268496B2 (en)2017-01-232025-04-08Abbott Diabetes Care Inc.Systems, devices and methods for analyte sensor insertion
US12239463B2 (en)2020-08-312025-03-04Abbott Diabetes Care Inc.Systems, devices, and methods for analyte sensor insertion

Also Published As

Publication numberPublication date
JPH0430543B2 (en)1992-05-22

Similar Documents

PublicationPublication DateTitle
JPS60173457A (en)Biosensor
JPH0452893B2 (en)
US5171689A (en)Solid state bio-sensor
EP0136362B1 (en)Biosensor
US5229282A (en)Preparation of biosensor having a layer containing an enzyme, electron acceptor and hydrophilic polymer on an electrode system
JPH0640086B2 (en) Biosensor
US5120420A (en)Biosensor and a process for preparation thereof
US4897173A (en)Biosensor and method for making the same
US3092465A (en)Diagnostic test device for blood sugar
JPH0524453B2 (en)
JPS63128252A (en)Biosensor
JPH03130662A (en)Device and method for separating plasma from blood and method of measuring analytic object in blood
JPH04221B2 (en)
JPS60185153A (en) immobilized enzyme membrane
JPS6024444A (en) biosensor
JPH01134246A (en)Biosensor
JP3796315B2 (en) Graphite nonwoven fabric as functional layer in diagnostic test kits
JPH01134245A (en) biosensor
WO1988009824A1 (en)Improvements in diagnostic test strips
JPS6191558A (en) biosensor
JPS6150055A (en)Biosensor
JPS63317097A (en) biosensor
JPS61213663A (en)Biosensor
JPH058776B2 (en)
JPS62137559A (en) biosensor

Legal Events

DateCodeTitleDescription
EXPYCancellation because of completion of term

[8]ページ先頭

©2009-2025 Movatter.jp